PUBLIC COMPANY
save$HRMYHarmony Biosciences Holdings, Inc.
$HRMY38.12-0.99%Plymouth Meeting, PA, USupdated 2h ago
community read0 votes
pipeline
5
marketed
1
phase 3
3
catalysts ytd
4
approvals ytd
1
recalls ytd
0
Pipeline(5)
pipeline depth5 products
3Phase 31Marketed1Unknown
Marketed
pitolisant hydrochloride
Prader-Willi Syndrome (PWS)
Histamine H3 receptor
Phase 3clemizole hydrochloride
Dravet Syndrome (Severe Myoclonic Epilepsy of Infancy)
Phase 3pitolisant GR
Narcolepsy
Phase 3pitolisant HD
Idiopathic Hypersomnia (IH)
drugWAKIX
1 INDICATIONS AND USAGE WAKIX is indicated for the treatm…
Histamine H3 receptor
Upcoming
Recent(90d)
view all catalysts →Insider activity
source: SEC Form 4routine RSU / option mechanics (5)
- Apr 7, 26tax coverZaeske Adam H. · CHIEF COMMERCIAL OFFICER3,173 sh
- Apr 7, 26option exerciseZaeske Adam H. · CHIEF COMMERCIAL OFFICER7,500 sh
- Apr 7, 26option exerciseZaeske Adam H. · CHIEF COMMERCIAL OFFICER7,500 sh
- Apr 2, 26grantAnastasiou Peter · CHIEF OPERATING OFFICER212,241 sh
- Apr 2, 26grantIgnelzi Troy A. · 17,710 sh
🐶 Hiring Signal
next earnings Nov 3, 2026
News
no news has mentioned this company yet
Data sources
last refreshed 54m ago
Found something off?
comments(0)
5-min edit window · permanent after that